The Food and Drug Administration approved a new treatment that can be given to all infants that would block the RSV virus from infecting the child, CNN reports, creating yet another helpful medical invention conservatives will undoubtedly revolt against.
The leading cause of hospitalization for young children in the United States, RSV is the second most-fatal illness for children in their first years of life, after malaria. The new treatment, nirsevimab, brand name Beyfortus, isn’t a vaccine that stimulates the body to produce antibodies; it’s essentially the antibodies themselves. A different treatment that acts similarly was earlier approved for children at high risk for the RSV infection, but nirsevimab is recommended for all children.